Digoxin clearance and serum beta-2-microglobulin in neonates

Area of Science:

• Neonatal Pharmacology
• Clinical Chemistry

Background:

• Digoxin is crucial for treating neonatal heart conditions.
• Accurate dosing requires understanding digoxin clearance (CLdig) in neonates.
• Reliable indicators for CLdig are needed for safe and effective therapy.

Purpose of the Study:

• To identify reliable indicators of digoxin clearance (CLdig) in neonates.
• To investigate correlations between CLdig and various biomarkers.
• To establish a method for individualizing digoxin dosage in this population.

Main Methods:

• Studied linear correlation of CLdig and 1/CLdig with serum beta 2-microglobulin (S beta 2-MG), creatinine, BUN, age, and weight.
• Analyzed data from 21 neonates with congenital heart disease on 25 occasions.
• Utilized regression analysis to determine the best predictive model.

Main Results:

• S beta 2-MG showed a strong correlation with 1/CLdig (r = 0.84, p < 0.0001).
• Creatinine and BUN had weaker correlations with 1/CLdig (r = 0.67 and 0.71).
• Age and weight did not significantly correlate with CLdig or 1/CLdig.

Conclusions:

• S beta 2-MG is a valuable indicator for estimating CLdig in neonates.
• The established regression equation using S beta 2-MG allows for prediction of CLdig.
• This facilitates individualized digoxin therapy and maintenance dose adjustments in neonates.